Making medicines affordable

Cipla Chairman Dr Yusuf Hamied donates Rs 8.7 Crore to Royal Society of Chemistry for next leg of Inspirational Science Programme.

geetanjali

Geetanjali Minhas | March 7, 2019 | Mumbai


#Inspirational Science Programme   #Royal Society of Chemistry   #Yusuf Hamied   #licensing   #India   #medicine   #Cipla  
Royal Society of Chemistry in India announces funding boost from philanthropist Dr Yusuf Hamied
Royal Society of Chemistry in India announces funding boost from philanthropist Dr Yusuf Hamied

Calling for a pragmatic and compulsive licensing system in healthcare, chairperson, Cipla, Dr Yusuf Hamied said that government must formalise essential drugs. Making a strong voice for compulsory licensing and voluntary licensing to make medicine affordable, he said that when a multinational company does not give individual license for essential drugs the government should step in, ask for license and give royalty payment. “Science has to be rewarded but not denied,” he said.      

Citing the example of multinational company, Gilead Sciences Inc.– that entered into voluntary licensing agreement against royalty payment for Hepatitis-C drug 'Sofosbovir' which brought down prices for patents in India – he said that out of the world’s 50 top selling drugs, 70 percent are made and marketed by companies that did not invent them and are in-licensed. “India should in-license. With 1.35 billion people in our country who cannot afford monopoly and despite very high malnutrition in India, Vitamin B1, B2, B6 Vitamin D, Vitamin E and Vitamin C are not made in India. We have to be self-reliant and not self-sufficient,” said the renowned scientist and business leader. He was announcing his continued support and expansion of Inspirational Science Programme along with the Royal Society of Chemistry (RSC) in India with a donation of Rs 8.7 crore.
 
The four year programme will train 20,000 teachers covering most regions in India and reach out to 2,400 under privileged students under Salters’ Chemistry Camps. Since its first phase, which started in Bangalore, the Yusuf Hamied Inspirational Chemistry Programme has trained 23,000 science teachers across 9,000 schools in 26 states between 2014 and 2018. More than 1,600 students from 500 schools attended 26 Salters’ Chemistry camps.
 
The four year programme will provide Indian teachers new tools for delivering engaging and effective science lessons and encourage students to reach the necessary standards to study science at university. “A main part of the new programme will be to explore the introduction of three new key enhancements, to translate teacher training content into selected local languages, to develop training modules to cover additional specific disciplines and to explore how mobile access to the Royal Society of Chemistry’s teaching resources could complement the programmes aims. After an exploratory phase, implementation of any additional activities would commence from 2020 onwards,” said Dr. Robert Parker, chief executive of the Royal Society of Chemistry.
 
Speaking to Governance Now Dr Parker said, “Science can be a creative and fulfilling career for children and have benefits for the world. India has massive talent that could be working on inspirational chemistry as we need chemistry developments to make life better – be it in the area of health care, renewable energy or environment. With 23,000 teachers in its first phase, it was three times the original number of teachers we had set out to train. The programme is developed from feedback received by the teachers in India to make it more relevant and suitable for them and the children they are trying to engage with.” 
 
Dr Hameid added that the next programme will be practical in nature and adapt to India’s needs particularly in the area of medicines. “We are toying with the idea to see how chemistry can be taught long distance and asked RSC to expand it into science. Along with science programmes, students will be taught to develop skills and use the knowledge imparted to be more productive. Our next set up with RSC is how we get in technology we don’t have in India to make some older drugs that we are not producing,” he said.  
 

Comments

 

Other News

Climate change is stealing sleep

Climate change has at least doubled the temperature-related sleep loss across 1,338 major cities worldwide over the past five decades, highlighting an emerging but often overlooked public health consequence of rising global temperatures. A new study by Climate Central estimates that between 2020 and

Cabinet approves Mobile Phone Manufacturing Scheme

The union cabinet chaired by PM Narendra Modi has approved the Mobile Phone Manufacturing Scheme (MPMS) with a budgetary outlay of Rs 62,500 crore. It aims to further scale up the production, deepen domestic value addition, strengthen supply chain resilience, enhance global competitiveness. It

Building infrastructure is only half the job

Recent stories of stolen railway wires, disappearing communication towers and missing public infrastructure are often treated as bizarre law-and-order failures of India. Yet they raise a more fundamental question. Why does the State often discover the disappearance of a public asset only after it has alrea

New Delhi’s Indo-Pacific strategy enters a new phase

India appears to be investing fresh dynamism in its Indo-Pacific strategy. At the time when the US, under president Donald Trump, has adopted a conciliatory approach towards China and has changed the name of America’s Indo-Pacific Command to just Pacific Command, India has quietly moved towards con

CAG flags major fiscal lapses in Maharashtra

Maharashtra`s fiscal management has come under sharp scrutiny after the Comptroller and Auditor General (CAG) of India, in its State Finances Audit Report for 2024-25, flagged significant budgetary inefficiencies, accounting irregularities, understatement of key fiscal indicators and widespread governanc

The health sector research we are not doing

Some neglect is loud. This kind is quiet. It sits in research never commissioned, data never collected, questions never asked. In South Asia, that quiet has let the region’s worst health problems stay understudied, underfunded, and out of sight of those who could act.  

Upcoming Conferences





Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter